John Marshall, MD, and Qian Shi, PhD, on Colon Cancer: Results of the IDEA Trial

2017 ASCO Annual Meeting
Tweet this page

John Marshall, MD, of Georgetown University, and Qian Shi, PhD, of the Mayo Clinic, discuss study findings on shortening the duration of adjuvant oxaliplatin-based therapy, linked to neurotoxicity, for patients with stage III colon cancer. (Abstract LBA1)

Advertisement

Advertisement



Advertisement

click me